---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-063189"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T06:32:10.337279+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Denali Capital files updated investor presentation for proposed merger with Longevity Biomedical

## Summary
- Exhibit 99.1 is an August 2023 investor presentation for the business combination with Longevity Biomedical, superseding the January 2023 version.
- The presentation will be used in meetings with investors; no specific new deal terms or financial projections are disclosed in the filing.
- Upon closing, each of Denali and Longevity will become wholly-owned subsidiaries of Holdco, renamed Longevity Biomedical, Inc.
- The transaction remains subject to regulatory and stockholder approvals; the registration statement was filed on March 29, 2023.

## SEC filing metadata
- accession: 0001213900-23-063189
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390023063189/0001213900-23-063189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390023063189/ea182794-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-063189
- JSON: https://secwatch.observer/filing/0001213900-23-063189.json
- Plain text: https://secwatch.observer/filing/0001213900-23-063189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.